Back
Lifecore Biomedical Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
39
LFCR
Lifecore Biomedical
Last Price:
5.68
Seasonality Move:
2.29%
7 Day Trial
ALL ACCESS PASS
$
7
Investing Today: The Best Way To Grow A Small Account
In his free guide, expert Joe Duffy reveals... click here to read on...Lifecore Biomedical Price Quote
$5.68
-0.25 (-4.22%)
(Updated: October 31, 2024 at 6:55 PM ET)
Lifecore Biomedical Key Stats
Sell
39
Lifecore Biomedical (LFCR)
is a Sell
Day range:
$5.74 - $5.98
52-week range:
$3.68 - $8.90
Dividend yield:
0%
P/E ratio:
17.94
P/S ratio:
1.58
P/B ratio:
0%
Volume:
68.8K
Avg. volume:
141.7K
1-year change:
-16.36%
Market cap:
$211.4M
Revenue:
$128.3M
EPS:
$0.05
How Much Does Lifecore Biomedical Make?
-
How Much Are Lifecore Biomedical's Sales Annually?
LFCR Revenues are $128.3M -
How Much Profit Does Lifecore Biomedical's Make A Year?
LFCR net income is $12M
Is Lifecore Biomedical Growing As A Company?
-
What Is Lifecore Biomedical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Lifecore Biomedical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Lifecore Biomedical Stock Price Performance
-
Did Lifecore Biomedical Stock Go Up Last Month?
Lifecore Biomedical share price went up by 20.28% last month -
Did LFCR's Share Price Rise Over The Last Year?
LFCR share price fell by -16.36% over the past 1 year
What Is Lifecore Biomedical 52-Week High & Low?
-
What Is Lifecore Biomedical’s 52-Week High Share Price?
Lifecore Biomedical has traded as high as $8.90 over the past 52 weeks -
What Is Lifecore Biomedical’s 52-Week Low Share Price?
Lifecore Biomedical has traded as low as $3.68 over the past 52 weeks
Lifecore Biomedical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lifecore Biomedical?
-
How Much Debt Does Lifecore Biomedical Have?
Total long term debt quarterly is $127.9M -
How Much Cash Does Lifecore Biomedical Have?
Cash and short term investments quarterly total is $5.5M -
What Is Lifecore Biomedical’s Book Value Per Share?
Book value per share is -0.13
Is Lifecore Biomedical Cash Flow Positive?
-
What Is LFCR Cash Flow From Operations?
Cash flow from operations (TTM) is $7.5M -
What Is Lifecore Biomedical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.7M -
What Is Lifecore Biomedical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$16.3M
Lifecore Biomedical Return On Invested Capital
-
Is Management Doing A Good Job?
LFCR return on invested capital is 5.48% -
What Is Lifecore Biomedical Return On Assets?
ROA measures how assets are converting to revenues and is 2.64% -
What Is LFCR Return On Equity?
ROE is a measure of profitability and is 252.9%
Lifecore Biomedical Earnings Date & Stock Price
-
What Is Lifecore Biomedical's Stock Price Today?
A single share of LFCR can be purchased today for 5.93 -
What Is Lifecore Biomedical’s Stock Symbol?
Lifecore Biomedical trades on the nasdaq under the ticker symbol: LFCR -
When Is Lifecore Biomedical’s Next Earnings Date?
The next quarterly earnings date for Lifecore Biomedical is scheduled on January 10, 2025 -
When Is LFCR's next ex-dividend date?
Lifecore Biomedical's next ex-dividend date is November 1, 2024 -
How To Buy Lifecore Biomedical Stock?
You can buy Lifecore Biomedical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lifecore Biomedical Competitors
-
Who Are Lifecore Biomedical's Competitors?
Below is a list of companies who compete with Lifecore Biomedical or are related in some way:
Lifecore Biomedical Dividend Yield
-
What Is LFCR Dividend Yield?
Lifecore Biomedical’s dividend yield currently is 0% -
What Is Lifecore Biomedical’s Payout Ratio?
Lifecore Biomedical’s payout ratio is 0% -
When Did Lifecore Biomedical Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Lifecore Biomedical’s Dividend Per Share?
Lifecore Biomedical pays a dividend of $0.00 per share
Lifecore Biomedical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 19.51% |
| Revenue: | 0.75% | 6.54% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 7.00 |
| Upside from Last Price: | 18.04% |